HK1143698A1 - Gel-like composition for external application comprising adenine compound - Google Patents

Gel-like composition for external application comprising adenine compound

Info

Publication number
HK1143698A1
HK1143698A1 HK10110095.1A HK10110095A HK1143698A1 HK 1143698 A1 HK1143698 A1 HK 1143698A1 HK 10110095 A HK10110095 A HK 10110095A HK 1143698 A1 HK1143698 A1 HK 1143698A1
Authority
HK
Hong Kong
Prior art keywords
gel
composition
external application
adenine compound
adenine
Prior art date
Application number
HK10110095.1A
Other languages
English (en)
Inventor
Misato Nakajo
Fumiki Harano
Kosaburo Wakamatsu
Kazuhiro Yagyu
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of HK1143698A1 publication Critical patent/HK1143698A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0208—Tissues; Wipes; Patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0212—Face masks
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/606—Nucleosides; Nucleotides; Nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/88—Two- or multipart kits
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Toxicology (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
HK10110095.1A 2007-08-06 2010-10-27 Gel-like composition for external application comprising adenine compound HK1143698A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2007204556 2007-08-06
PCT/JP2008/063982 WO2009020104A1 (ja) 2007-08-06 2008-08-04 アデニン化合物を含有するゲル状外用組成物

Publications (1)

Publication Number Publication Date
HK1143698A1 true HK1143698A1 (en) 2011-01-07

Family

ID=40341336

Family Applications (1)

Application Number Title Priority Date Filing Date
HK10110095.1A HK1143698A1 (en) 2007-08-06 2010-10-27 Gel-like composition for external application comprising adenine compound

Country Status (11)

Country Link
US (1) US9597266B2 (pt)
EP (1) EP2174647B1 (pt)
JP (2) JP5791227B2 (pt)
KR (1) KR101604778B1 (pt)
CN (1) CN101778619B (pt)
AU (1) AU2008284807B2 (pt)
CA (1) CA2694061C (pt)
ES (1) ES2657403T3 (pt)
HK (1) HK1143698A1 (pt)
TW (1) TWI435734B (pt)
WO (1) WO2009020104A1 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102458351B (zh) * 2009-06-19 2014-04-16 大塚制药株式会社 皮肤水分透过功能异常的预防或治疗剂
US20130129651A1 (en) * 2010-08-03 2013-05-23 Hayashibara Co., Ltd. Agent for enhancing the effect of skin-whitening ingredients and uses thereof
EP2465581B1 (en) * 2010-12-15 2020-02-05 Energenesis Biomedical Co., Ltd. Non-therapeutic use of a composition for promoting hair growth
JP6750932B2 (ja) * 2015-06-24 2020-09-02 花王株式会社 皮膚の触覚測定方法および化粧料の性能評価方法
JP6389308B1 (ja) * 2017-08-23 2018-09-12 一丸ファルコス株式会社 皮膚外用剤

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3871967A (en) * 1974-01-11 1975-03-18 Boehringer Sohn Ingelheim Synthetic nutrient medium for microorganisms and method of use
FR2557452B1 (fr) * 1983-12-28 1986-08-14 Roussel Uclaf Nouvelles compositions pour les soins de la peau renfermant de l'huile d'onagre et des traits tissulaires de rate
KR20010080324A (ko) * 1998-10-26 2001-08-22 조셉 에프. 엑스. 맥과이얼 아데노신 또는 아데노신 유사체를 사용한 피부 치료방법
JP2000226325A (ja) 1998-12-03 2000-08-15 Kao Corp シート化粧料
CN1124127C (zh) * 1998-12-03 2003-10-15 花王株式会社 片状化妆品
EP1200519A1 (en) * 1999-07-06 2002-05-02 The Procter & Gamble Company Pre-formed, self-adhesive sheet devices suitable for topical application
JP3994257B2 (ja) 2000-11-22 2007-10-17 大塚製薬株式会社 Ｏ／ｗ型乳化組成物及びその調製方法
JP2003040793A (ja) 2001-07-24 2003-02-13 Arie:Kk シートパック化粧料、飲用カプセル及び飲用錠剤
JP2003063924A (ja) * 2001-08-24 2003-03-05 Toshin Kagaku Kk フィルム状皮膚外用剤
ES2428027T3 (es) * 2002-05-20 2013-11-05 Otsuka Pharmaceutical Co., Ltd. Composición que comprende adenosín-monofosfato para el tratamiento del melasma
JP4093346B2 (ja) * 2002-05-20 2008-06-04 マイコール株式会社 美顔用発熱体
MXPA05000761A (es) * 2002-07-19 2005-04-19 Procter & Gamble Composicion de mascarilla que contiene una composicion liquida emulsionada.
JP4129574B2 (ja) 2002-08-06 2008-08-06 大塚製薬株式会社 老化防止剤
AU2003276707A1 (en) 2002-10-30 2004-05-25 Showa Denko K.K. Adhesive composition for dermal patch and production process thereof
US20040161435A1 (en) 2003-02-14 2004-08-19 Gupta Shyam K. Skin Firming Anti-Aging Cosmetic Mask Compositions
US20040219124A1 (en) 2003-05-01 2004-11-04 Gupta Shyam K. Cosmetic and Pharmaceutical Masks Based on Ion-Pair Delivery System
CA2541584C (en) 2003-10-08 2013-02-26 Otsuka Pharmaceutical Co., Ltd. Composition for promoting collagen production comprising a purine nucleic acid-related substance and a pyrimidine nucleic acid-related substance
JP2005272645A (ja) 2004-03-25 2005-10-06 Fancl Corp 多孔質素材
JP2005320264A (ja) 2004-05-06 2005-11-17 Daiya Seiyaku Kk 外用ゲル基剤及び容器充填型パッド材
JP2006056543A (ja) * 2004-08-18 2006-03-02 Kanae Technos:Kk パック用ゲルシート包装体
JP4925579B2 (ja) 2004-12-28 2012-04-25 大塚製薬株式会社 水中油型エマルジョンからなる固形組成物
JP3919123B1 (ja) 2005-12-26 2007-05-23 株式会社ベスビオ 安定なグルタチオンを含有する液状皮膚外用剤及びそれを含有する美白用及び美肌用液状皮膚外用剤

Also Published As

Publication number Publication date
ES2657403T3 (es) 2018-03-05
JP5791227B2 (ja) 2015-10-07
AU2008284807A1 (en) 2009-02-12
TW200914059A (en) 2009-04-01
US20110224163A1 (en) 2011-09-15
US9597266B2 (en) 2017-03-21
CN101778619B (zh) 2012-05-23
JPWO2009020104A1 (ja) 2010-11-04
WO2009020104A1 (ja) 2009-02-12
EP2174647B1 (en) 2017-12-13
AU2008284807B2 (en) 2013-03-14
CN101778619A (zh) 2010-07-14
KR20100040723A (ko) 2010-04-20
CA2694061C (en) 2015-11-03
JP2015157874A (ja) 2015-09-03
JP6486773B2 (ja) 2019-03-20
CA2694061A1 (en) 2009-02-12
TWI435734B (zh) 2014-05-01
KR101604778B1 (ko) 2016-03-18
EP2174647A1 (en) 2010-04-14
EP2174647A4 (en) 2015-07-22

Similar Documents

Publication Publication Date Title
ZA200906253B (en) Novel adenine compound
EP2138497A4 (en) NEW ADENINE CONNECTION
GB0700534D0 (en) Composition
GB0724905D0 (en) Boron-containing compositions
GB0722550D0 (en) Composition
HK1179514A1 (en) Composition for external use
HUS1500007I1 (hu) Radiogyógyszerészeti kompozíció
PL2178973T3 (pl) Pęczniejące kompozycje
GB0724498D0 (en) Slow release compositions
GB0710888D0 (en) Composition
HK1143698A1 (en) Gel-like composition for external application comprising adenine compound
HK1147698A1 (en) Composition for external application
GB0714569D0 (en) Composition
GB0705885D0 (en) Composition
GB0706343D0 (en) Composition
GB0702446D0 (en) Composition
GB0706739D0 (en) Composition
GB0704651D0 (en) Composition
GB0707972D0 (en) Composition
GB0704659D0 (en) Composition
GB2447012B (en) Composition for combating epistaxis
GB0713976D0 (en) Composition
GB0710559D0 (en) Composition
IL206473A0 (en) Stable elsamitrucin salt formulations
GB0711768D0 (en) Composition